AbCellera
AbCellera41About
What does AbCellera do?
AbCellera is a technology company that partners with drug developers to discover and develop antibody therapeutics. Their AI-powered drug discovery platform integrates high-throughput screening, genomics, and AI to accelerate the identification of therapeutic antibodies from natural immune responses.
What is AbCellera's revenue?
StartupHub estimates AbCellera's annual revenue at $707K (range $433K to $4.3M, 28% confidence), based on comparable companies in the sector.
What is AbCellera's valuation?
StartupHub estimates AbCellera's effective valuation at $35.1M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.
How much funding has AbCellera raised?
AbCellera has raised a total of $10M in funding. The most recent round on record is Series A.
Where is AbCellera headquartered?
AbCellera is headquartered in Vancouver, Canada.
When was AbCellera founded?
AbCellera was founded in 2012.
What industry does AbCellera operate in?
AbCellera operates in Biotech, Drug Discovery, Genomics, AI Drug Discovery, Antibody Therapeutics, Single-Cell Analysis.
No comments yet. Be the first to share your take.